BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35973085)

  • 1. Letter to the Editor in Response to "Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients" Published in December 2021.
    Dain AS; Whitworth H; Raffini L
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):44-45. PubMed ID: 35973085
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients.
    McDaniel CG; Tracy ET
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):45. PubMed ID: 36036523
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients.
    McDaniel CG; Commander SJ; DeLaura I; Cantrell S; Leraas HJ; Moore CB; Reed CR; Pahl KS; Tracy ET
    J Pediatr Hematol Oncol; 2022 Aug; 44(6):323-335. PubMed ID: 34862349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
    Zhang X; Yang X; Jiao H; Liu X
    Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.
    Yousefi P; Soltani S; Siri G; Rezayat SA; Gholami A; Zafarani A; Razizadeh MH; Alborzi E; Mokhtary-Irani G; Abedi B; Karampoor S; Tabibzadeh A; Farahani A
    J Clin Lab Anal; 2023 Jun; 37(11-12):e24941. PubMed ID: 37431777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.
    Khezri MR; Varzandeh R; Ghasemnejad-Berenji M
    Cell Mol Biol Lett; 2022 Jan; 27(1):6. PubMed ID: 35016612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.
    Kinaneh S; Khamaysi I; Karram T; Hamoud S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34132790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
    Yamada S; Asakura H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major coagulation disorders and parameters in COVID-19 patients.
    Teimury A; Khameneh MT; Khaledi EM
    Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Ghana-UK haematology "heparin" partnership.
    Olayemi E; Davies R; Bates I
    Br J Haematol; 2020 Nov; 191(3):e96-e97. PubMed ID: 32798238
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation and wound repair during COVID-19.
    Menachery VD; Gralinski LE
    J Heart Lung Transplant; 2021 Oct; 40(10):1076-1081. PubMed ID: 34334300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
    Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
    Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19-associated coagulopathy in children: A multicenter observational cohort study.
    Zabeida A; Winikoff R; Pelland-Marcotte MC; Charlebois J; Sabapathy C
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30079. PubMed ID: 36326142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Levi M; Iba T
    Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal for the management of COVID-19-associated coagulopathy in children.
    Palomino-Nolasco S; Pacheco-González GM; Saldaña-Díaz CV
    Gac Med Mex; 2021; 157(6):639. PubMed ID: 35108258
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronavirus Disease 2019-Associated Coagulopathy.
    Lippi G; Sanchis-Gomar F; Favaloro EJ; Lavie CJ; Henry BM
    Mayo Clin Proc; 2021 Jan; 96(1):203-217. PubMed ID: 33413819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to the Letter to the Editor on "Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection".
    Tso WW; Kwan MY; Ip P; Chan JF
    J Med Virol; 2023 Sep; 95(9):e29095. PubMed ID: 37698141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Update 2021: COVID-19 from the Perspective of Haematology and Haemostaseology].
    Spiekermann K; Subklewe M; Hildebrandt M; Humpe A; von Bergwelt-Baildon M
    Dtsch Med Wochenschr; 2021 Jul; 146(13-14):899-903. PubMed ID: 34256404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.